Enright Patrick G's Form 4 filing
Veradermics, Inc (MANE) · filed Feb 5, 2026
- Accession no.
- 0001628280-26-005904
- Filed
- Feb 5, 2026
- Trade date
- Feb 3-5, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market purchases total $18.3M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Enright Patrick GCIK 0001253886 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2026 | Common Stock | CConversionAcquired | +1,236,631 | – | – | 1,236,631 | Indirect | |
| Feb 5, 2026 | Common Stock | CConversionAcquired | +1,171,121 | – | – | 2,407,752 | Indirect | |
| Feb 5, 2026 | Common Stock | CConversionAcquired | +1,171,121 | – | – | 1,171,121 | Indirect | |
| Feb 5, 2026 | Common Stock | PPurchaseAcquired | +192,647 | $17.00 | +$3,274,999 | 2,600,399 | Indirect | |
| Feb 5, 2026 | Common Stock | PPurchaseAcquired | +882,353 | $17.00 | +$15,000,001 | 2,053,474 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2026 | Common Stock | CConversionDisposed | −1,236,631 | – | – | 0 | Indirect | |
| Feb 5, 2026 | Common Stock | CConversionDisposed | −1,171,121 | – | – | 0 | Indirect | |
| Feb 5, 2026 | Common Stock | CConversionDisposed | −1,171,121 | – | – | 0 | Indirect | |
| Feb 3, 2026 | Common Stock | AGrant or awardAcquired | +45,131 | $0.00 | $0 | 45,131 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.